2004 |
Diagnosed with dilated cardiomyopathy. |
From 2004 to 2015 |
More than 20 hospitalizations for exacerbation of chronic heart failure (HF) with a progressive reduction of the ejection fraction (EF). |
2015 |
Balloon angioplasty and stent implantation in circumflex (Cx) artery. Biventricular implantable cardioverter-defibrillator implantation for primary prevention. |
September 2017 |
MitraClip placement for a severe functional mitral regurgitation. |
October 2017 |
First access to our departmental HF Clinic. |
From October 2017 to May 2019 |
The patient went through numerous exacerbations, despite optimal medical therapy. |
May 2019 |
Evidence of reduced EF (20%) and decision to start cyclic levosimendan infusion. |
June 2019 |
CardioMEMS implantation. |
September 2019 |
Scheduled hospitalization for levosimendan infusion. |
December 2019 |
Scheduled hospitalization for levosimendan infusion. |
From December 2019 to February 2020 |
After December 2019, the cardiologist continued to monitor the patient, making therapy adjustments according to diastolic PA pressure. No further levosimendan infusions were made between December 2019 and February 2020. |